register

News & Trends - Pharmaceuticals

Sanofi inks deal with Melbourne-based manufacturing company

Health Industry Hub | April 19, 2024 |

Pharma News: Sanofi has inked a deal with Melbourne-based pharmaceutical manufacturing company, focusing on manufacturing of messenger RNA (mRNA) vaccines.

Under this master service agreement, IDT Australia will collaborate closely with Sanofi to formulate and manufacture cGMP-compliant mRNA-based vaccines for clinical trials, targeting various medical needs currently unmet. The company also highlighted that it is one of the few aseptic sterile fill (injectables) facilities to complete mRNA downstream processing in Asia Pacific.

Paul McDonald, IDT Australia CEO, stated “We are thrilled to secure an agreement with Sanofi, progressing their groundbreaking science into cGMP manufacture to deliver mRNA product solutions to unmet medical needs.”

Sanofi’s Translational Science Hub (TSH) is a pioneering $280 million project with partners Griffith University, University of Queensland, and the Queensland Government. Leveraging the exceptional expertise and infrastructure in Queensland, this hub is designed to focus on mRNA vaccine technology and broader translational science.

“This collaboration with Sanofi underscores IDT Australia’s unique expertise and world-class facilities while reinforcing our position as a trusted partner in the global pharmaceutical industry,” added McDonald.

The imminent initial order, valued at approximately AUD $3 – $3.5 million, excludes expenses related to storage, shipping, and equipment procurement.

In a separate development, in January 2024, Sanofi acquired clinical-stage biopharmaceutical company, Inhibrx, for $1.7 billion. Specialising in oncology and orphan diseases, Inhibrx brings a robust pipeline of innovative biologic therapies to Sanofi’s portfolio.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


Human Resources

The return-to-office debate: Where are we in the pendulum's swing?

The return-to-office debate: Where are we in the pendulum’s swing?

Health Industry Hub | May 24, 2024 |

People & Culture: The evolution of hybrid and flexible workplaces has yielded mixed results across the healthcare sector, with some […]

More


News & Trends - MedTech & Diagnostics

Cardinal Health launches local facility for reprocessing of single-use medical devices

Cardinal Health launches local facility for reprocessing of single-use medical devices

Health Industry Hub | May 24, 2024 |

MedTech & Diagnostics News: Cardinal Health is set to launch a cutting-edge facility in Australia dedicated to the reprocessing of […]

More


Medical

New ophthalmic centre to partner on pharma and medtech clinical trials

New ophthalmic centre to partner on pharma and medtech clinical trials

Health Industry Hub | May 24, 2024 |

Medical: The Victorian Deputy Premier and Minister for Medical Research, the Hon Ben Carroll, has launched a cutting-edge ophthalmic clinical […]

More


News & Trends - Pharmaceuticals

Private sector, government and academia gather to tackle barriers in vaccine value chain

Private sector, government and academia gather to tackle barriers in vaccine value chain

Health Industry Hub | May 24, 2024 |

Pharma News: An ‘invite only’ vaccine thought leadership event, aimed at addressing gaps in Australia’s vaccine ecosystem and maximising the […]

More


This content is copyright protected. Please subscribe to gain access.